Molecular subtypes and survival patterns of endometrial cancer in a South Indian cohort
International Journal of Gynecology & Obstetrics · 2026
DOI: 10.1002/ijgo.70837 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Gynecology & Obstetrics, 2026. Verfasst von Santhosh Kuriakose und 13 weiteren Autor:innen. Beteiligte Einrichtung: Gynecologic Oncology Division, Department of Obstetrics and Gynecology, Government Medical College, Kozhikode (GMCK), Institute of Maternal and Child…. Hauptthemen laut MEDLINE: Endometrial Neoplasms, DNA Polymerase II. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Science and Engineering Research Board (SERB) Anusandhan National Research Foundation, Department of Science and Technology, Government of India, Science and Engineering Research Board.
Abstract (Originalsprache)
Objective
This study investigates outcomes of The Cancer Genome Atlas (TCGA)‐surrogate molecular types of endometrial cancer in South Indian patients, including polymerase epsilon (POLE)‐mutated, mismatch repair‐deficient (MMRd), p53 aberrant, and no specific molecular profile (NSMP) types.
Methods
The retrospective cohort, followed‐up prospectively consisted of 151 patients from two institutions in Kerala, India: Government Medical College, Kozhikode, and MVR Cancer Center. The study spanned from January 1, 2016, to October 31, 2024. Sanger sequencing of the POLE gene (exons 9 and 13), TP53 (exons 5–8), CTNNB1, and PTEN genes, along with immunohistochemistry for mismatch repair (MMR) proteins, p53, estrogen receptor, and progesterone receptor, was performed to determine molecular types and associated variables.
Results
The study identified four subtypes: 39 POLE mutated (25.8%), 44 MMRd (29.1%), 29 p53 aberrant (19.2%), and 39 NSMP (25.8%). The 5‐year recurrence‐free survival (RFS) rates are POLE mutated (69%), MMRd (87%), p53abn (89%), and NSMP (64%) ( P = 0.012). The study identified a “non‐pathogenic” POLE‐mutated subtype showing poor outcomes for overall survival (OS), disease‐specific survival (DSS) and recurrence‐free survival (RFS) (hazard ratios [HRs] for OS 5.45, P = 0.010; HR for DSS 4.83, P = 0.020; HR for RFS 4.12, P = 0.017) in multivariable analysis. Follow‐up averaged 5.1 years. Estrogen receptor‐positive low‐grade endometrioid POLE‐mutated tumors demonstrated excellent survival, while high‐grade tumors negatively affected the POLE‐mutated group. MMRd subtype, despite presenting in advanced stages with high‐risk uterine factors, had excellent prognosis. The p53 aberrant group, predominantly with endometrioid histology and low‐grade tumors, also showed good prognosis with standard treatment protocols. NSMP subtype revealed unfavorable outcome. Neither CTNNB1 mutation or ER PR status was noted to be a determinant of the poor outcome. Multiple‐classifier tumors (>1 TCGA‐surrogate type) were identified, with POLEmut‐p53 being the largest group, showing characteristics similar to POLEmut.
Conclusion
The study's findings diverge from prognostic implications of TCGA‐surrogate molecular types, suggesting genetic diversity and ethnicity as potential outcome determinants in South Indian endometrial cancer patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Gynecologic Oncology Division, Department of Obstetrics and Gynecology, Government Medical College, Kozhikode (GMCK), Institute of Maternal and Child Health Block, Kozhikode, Kerala, India.
- Multidisciplinary Research Unit, Government Medical College, Kozhikode, Kerala, India.
- Department of Pathology, Government Medical College, Kozhikode, Kerala, India.
- Research Officer MRU-MDL, Government Medical College, Kozhikode, Kerala, India.
- Department of Obstetrics and Gynecology, Government Medical College, Kozhikode, Kerala, India.
- Department of Radiation Oncology, Tertiary Cancer Care Center, Government Medical College, Kozhikode, Kerala, India.
ORCID-Profile: Santhosh Kuriakose, Dhananjayan Dhanasooraj
Förderung
- Science and Engineering Research Board (SERB) Anusandhan National Research Foundation, Department of Science and Technology, Government of India
- Science and Engineering Research Board
Zitieren
APA
Kuriakose, S., Dhanasooraj, D., Padinjarayil Manakkattu, S., Saphia, S., Sona, V. P., Manjula Anupama, A., Ramachandran, A., Vijaykumar, B., Susan, N., Mathath, D., Karumathil Puthiyaveettil, A., Warrier, N., Pichakassery Sankaranarayanan, S., & Chandrathil Parameswaran Nair, V. (2026). Molecular subtypes and survival patterns of endometrial cancer in a South Indian cohort. International Journal of Gynecology & Obstetrics. https://doi.org/10.1002/ijgo.70837
Vancouver
Kuriakose S, Dhanasooraj D, Padinjarayil Manakkattu S, Saphia S, Sona VP, Manjula Anupama A, et al. Molecular subtypes and survival patterns of endometrial cancer in a South Indian cohort. International Journal of Gynecology & Obstetrics. 2026. doi:10.1002/ijgo.70837
BibTeX
@article{Kuriakose2026,
author = {Kuriakose, Santhosh and Dhanasooraj, Dhananjayan and Padinjarayil Manakkattu, Shiny and Saphia, Shammy and Sona, Valiya Parambath and Manjula Anupama, Achyuthan and Ramachandran, Amrutha and Vijaykumar, Bindu and Susan, Nayana and Mathath, Dinesan and Karumathil Puthiyaveettil, Aravindan and Warrier, Narayanankutty and Pichakassery Sankaranarayanan, Sreedharan and Chandrathil Parameswaran Nair, Vijayan},
title = {Molecular subtypes and survival patterns of endometrial cancer in a South Indian cohort},
journal = {International Journal of Gynecology & Obstetrics},
year = {2026},
doi = {10.1002/ijgo.70837}
}
EUVIMED